Michael Fricker

5.5k total citations · 1 hit paper
71 papers, 4.1k citations indexed

About

Michael Fricker is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Michael Fricker has authored 71 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Physiology, 26 papers in Pulmonary and Respiratory Medicine and 26 papers in Immunology. Recurrent topics in Michael Fricker's work include Asthma and respiratory diseases (32 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers) and IL-33, ST2, and ILC Pathways (11 papers). Michael Fricker is often cited by papers focused on Asthma and respiratory diseases (32 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers) and IL-33, ST2, and ILC Pathways (11 papers). Michael Fricker collaborates with scholars based in Australia, United Kingdom and United States. Michael Fricker's co-authors include Guy C. Brown, Aviva M. Tolkovsky, Vilmantė Borutaitė, Michael P. Coleman, Peter G. Gibson, Philip M. Hansbro, Jonas J. Neher, Clotilde Théry, Kurt Blaser and Mübeccel Akdis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Michael Fricker

66 papers receiving 4.0k citations

Hit Papers

align trajectories

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Fricker Australia	33	1.5k	1.1k	1.1k	745	684	71	4.1k
Egle Solito United Kingdom	42	3.5k 2.4×	772 0.7×	2.1k 1.9×	650 0.9×	760 1.1×	111	5.4k
Won‐Ha Lee South Korea	37	1.4k 1.0×	411 0.4×	1.5k 1.4×	999 1.3×	192 0.3×	119	4.2k
Yoshiyuki Matsuo Japan	33	1.8k 1.2×	460 0.4×	649 0.6×	808 1.1×	201 0.3×	99	3.9k
Bernard Dugas France	34	897 0.6×	1.2k 1.0×	1.6k 1.5×	524 0.7×	159 0.2×	113	4.3k
Bernard Robaye Belgium	40	1.9k 1.3×	643 0.6×	968 0.9×	256 0.3×	290 0.4×	100	4.7k
G. Enrico Rovati Italy	32	1.7k 1.1×	1.1k 0.9×	691 0.6×	147 0.2×	392 0.6×	107	3.8k
Riccardo Bertini Italy	35	1.2k 0.8×	327 0.3×	2.0k 1.8×	293 0.4×	255 0.4×	75	4.2k
Yoshihide Kanaoka United States	49	2.5k 1.7×	2.4k 2.1×	2.0k 1.9×	176 0.2×	672 1.0×	93	6.8k
Stuart Farrow United Kingdom	36	2.5k 1.7×	1.2k 1.1×	1.8k 1.7×	138 0.2×	596 0.9×	72	6.2k
Sanjay B. Maggirwar United States	43	2.0k 1.4×	452 0.4×	1.3k 1.2×	636 0.9×	378 0.6×	118	5.1k

Countries citing papers authored by Michael Fricker

Since Specialization

Citations

This map shows the geographic impact of Michael Fricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fricker more than expected).

Fields of papers citing papers by Michael Fricker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fricker. The network helps show where Michael Fricker may publish in the future.

Co-authorship network of co-authors of Michael Fricker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fricker. A scholar is included among the top collaborators of Michael Fricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fricker. Michael Fricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hamada, Yuto, Dennis Thomas, Vanessa M. McDonald, et al.. (2025). Clinical remission in severe asthma treated with biologics and macrolides: Definition, prevalence, associated factors, and future perspectives. Allergology International. 75(1). 15–25.

2.

Hamada, Yuto, Peter G. Gibson, Vanessa Clark, et al.. (2025). Dysfunctional Breathing and Depression Are Core Extrapulmonary and Behavior/Risk Factor Traits in Type 2–High Severe Asthma. The Journal of Allergy and Clinical Immunology In Practice. 13(7). 1743–1754.e12.

3.

Hamada, Yuto, Dennis Thomas, Vanessa M. McDonald, et al.. (2025). Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Annals of Allergy Asthma & Immunology. 135(5). 537–546.e12. 2 indexed citations

4.

Fricker, Michael & Ravi Lokwani. (2025). COPD: the role of neutrophils in inflammation, pathophysiology, and as drug targets. Clinical Science. 139(20). 1199–1214. 1 indexed citations

5.

Hamada, Yuto, Dennis Thomas, Erin S. Harvey, et al.. (2024). Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. European Respiratory Journal. 65(1). 2400782–2400782. 5 indexed citations

6.

Hamada, Yuto, Peter G. Gibson, Erin S. Harvey, et al.. (2024). Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 13(2). 333–342.e9. 3 indexed citations

7.

Fricker, Michael, et al.. (2022). T2-low: what do we know?. Annals of Allergy Asthma & Immunology. 129(2). 150–159. 22 indexed citations

8.

Gibson, Peter G., et al.. (2021). Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma. Allergy Asthma and Immunology Research. 13(3). 450–450. 13 indexed citations

9.

Gibson, Peter G., et al.. (2021). Airway monocyte modulation relates to tumour necrosis factor dysregulation in neutrophilic asthma. ERJ Open Research. 7(3). 131–2021. 11 indexed citations

10.

Lü, Zhe, Hannelore P. Van Eeckhoutte, Gang Liu, et al.. (2021). Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 204(6). 667–681. 123 indexed citations

11.

Baines, Katherine J., Netsanet A. Negewo, Peter G. Gibson, et al.. (2020). <p>A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD</p>. International Journal of COPD. Volume 15. 1577–1590. 10 indexed citations

12.

Fricker, Michael, Ling Qin, Katherine J. Baines, et al.. (2020). Relationship of sputum mast cells with clinical and inflammatory characteristics of asthma. Clinical & Experimental Allergy. 50(6). 696–707. 20 indexed citations

13.

Baines, Katherine J., Jodie L. Simpson, Hayley A. Scott, et al.. (2020). Neutrophilic asthma features increased airway classical monocytes. Clinical & Experimental Allergy. 51(2). 305–317. 26 indexed citations

14.

Fricker, Michael, Hannelore Van Eeckhoutte, Anne Verhamme, et al.. (2019). Necroptosis is activated in and drives pathogenesis of COPD. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

15.

Lokwani, Ravi, Peter Wark, Katherine J. Baines, et al.. (2019). <p>Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression</p>. International Journal of COPD. Volume 14. 2517–2525. 12 indexed citations

16.

Baines, Katherine J., Michael Fricker, Vanessa M. McDonald, et al.. (2019). Sputum transcriptomics implicates increased p38 signalling activity in severe asthma. Respirology. 25(7). 709–718. 22 indexed citations

17.

Liu, Gang, Sean Mateer, Alan Hsu, et al.. (2019). Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome. Mucosal Immunology. 12(4). 862–873. 44 indexed citations

18.

Baxter, Paul, Karen Bell, Philip Hasel, et al.. (2015). Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system. Nature Communications. 6(1). 6761–6761. 118 indexed citations

19.

Wilkinson, Simon, Jim O’Prey, Michael Fricker, & Kevin M. Ryan. (2009). Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity. Genes & Development. 23(11). 1283–1288. 59 indexed citations

20.

Müller, Ulrich, Cezmi A. Akdiş, Michael Fricker, et al.. (1998). Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom☆☆☆★★★. Journal of Allergy and Clinical Immunology. 101(6). 747–754. 370 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact